Vaccination against the Epstein-Barr virus
Epstein–Barr virus (EBV) was the first human tumor virus being discovered and remains to date the only human pathogen that can transform cells in vitro. 55 years of EBV research have now brought us to the brink of an EBV vaccine. For this purpose, recombinant viral vectors and their heterologous pri...
Հիմնական հեղինակներ: | Rühl, J, Leung, CS, Münz, C |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Springer Nature
2020
|
Նմանատիպ նյութեր
-
Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
: Christian Münz
Հրապարակվել է: (2020-06-01) -
Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
: Christian Münz
Հրապարակվել է: (2017-11-01) -
Immune Escape by Non-coding RNAs of the Epstein Barr Virus
: Christian Münz
Հրապարակվել է: (2021-06-01) -
Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection
: Christian Münz
Հրապարակվել է: (2021-12-01) -
Vaccination against Epstein–Barr Latent Membrane Protein 1 Protects against an Epstein–Barr Virus-Associated B Cell Model of Lymphoma
: Wesley I. Soo Hoo, և այլն
Հրապարակվել է: (2023-07-01)